1. Chemotherapy induced cardiotoxicity: on the way to personalized risk stratification based on genetic variants. (11th May 2022) Authors: Boen, H; Loeys, B; Van Laer, L; Heidbuchel, H; Alaerts, M; Franssen, C; Van Craenenbroeck, EM Journal: European journal of preventive cardiology Issue: Volume 29(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Doxorubicin induces measurable vascular toxicity: assessment in a clinical and preclinical study. (10th June 2022) Authors: Bosman, M; Boen, H; Franssen, C; Kruger, DN; Neutel, CHG; Favere, K; Van Asbroeck, B; Goovaerts, I; De Meyer, GRY; Van Craenenbroeck, EM; Guns, PJDF Journal: Cardiovascular research Issue: Volume 118(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022) Authors: Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P5650Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling. (28th August 2018) Authors: Dal Canto, E; Van Heerebeek, L; Franssen, C; Verheugt, F W A; Riezebos, R; Paulus, W J Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗